000 01370 a2200349 4500
005 20250517234210.0
264 0 _c20181211
008 201812s 0 0 eng d
022 _a2376-1032
024 7 _a10.18553/jmcp.2018.24.9-a.s30
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBillings, Liana K
245 0 0 _aHealth-Related Quality of Life Assessments with Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes Mellitus.
_h[electronic resource]
260 _bJournal of managed care & specialty pharmacy
_cSep 2018
300 _aS30-S41 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aDiabetes Mellitus, Type 2
_xblood
650 0 4 _aDrug Administration Schedule
650 0 4 _aGlucagon-Like Peptide-1 Receptor
_xblood
650 0 4 _aHumans
650 0 4 _aHypoglycemic Agents
_xadministration & dosage
650 0 4 _aInsulin
_xblood
650 0 4 _aQuality of Life
_xpsychology
650 0 4 _aTreatment Outcome
650 0 4 _aGlucagon-Like Peptide-1 Receptor Agonists
700 1 _aHandelsman, Yehuda
700 1 _aHeile, Michael
700 1 _aSchneider, Doron
700 1 _aWyne, Kathleen
773 0 _tJournal of managed care & specialty pharmacy
_gvol. 24
_gno. 9-a Suppl
_gp. S30-S41
856 4 0 _uhttps://doi.org/10.18553/jmcp.2018.24.9-a.s30
_zAvailable from publisher's website
999 _c28777663
_d28777663